New Delhi [India], August 6 (ANI): US pharma giant Johnson and Johnson on Friday said it has applied for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine Janssen to the Government of India.
New Delhi [India], August 5 (ANI): Bharat Biotech manufactured COVID-19 vaccine Covaxin on Thursday received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities.
New Delhi [India], July 12 (ANI): India's drug regulator Drugs Controller General of India (DCGI) will consider giving emergency use authorisation (EUA) to Zydus Cadila for its COVID-19 vaccine ZyCoV-D in a few more days, sources told ANI.
New Delhi [India], July 1 (ANI): The pharmaceutical firm Zydus Cadila on Thursday informed that it has applied for emergency use authorisation (EUA) from the Drug Controller General of India (DCGI) for its DNA vaccine ZyCoV-D against coronavirus disease and stated that they expect to produce
New Delhi [India], July 1 (ANI): Pharmaceutical major Zydus Cadila on Thursday applied for Emergency Use Authorisation (EUA) seeking approval from the Drugs Controller General of India (DCGI) for the launch of their ZyCoV-D vaccine for 12 years and above, sources said .
New Delhi [India], June 18 (ANI): Pharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the next seven-eight days.
Mumbai (Maharashtra) [India], June 16 (ANI/PNN): Thermo Fisher Scientific today announced the introduction of the new and innovative Accula SARS-CoV-2 Test that delivers gold-standard reverse transcription-polymerase chain reaction (RT-PCR) detection of SARS-CoV-2 in a point-of-care format.
New Delhi [India], June 11 (ANI): Reacting to the United States Food and Drug Administration (FDA)'s rejection of Bharat Biotech's Covaxin jab for emergency use authorization, the Union Health Ministry on Friday said that it respects the decision taken by the authority but it will not hav
Pennsylvania [US], June 11 (ANI): Bharat Biotech's US partner Ocugen Inc said that the company will no longer pursue an Emergency Use Authorization (EUA) for COVAXIN and the US Food and Drug Administration (FDA) has recommended that the company go for the Biologics Licence Application (BL
New Delhi [India], June 2 (ANI): Amid discussions over possible legal protection to Pfizer and Moderna over use of their COVID-19 vaccines in India, a former senior ICMR official has said that no company in India's vaccination history has ever paid indemnity and the government, which is the
Hyderabad (Telangana) [India], June 1 (ANI): Biological E. Limited has tied up with Canada's Providence Therapeutics to locally manufacture its mRNA coronavirus disease (COVID-19) vaccine, the Hyderabad-based company announced on Tuesday, adding it will run a pivotal trial in India, and seek
New Delhi [India], April 13 (ANI): Union Health Minister Dr Harsh Vardhan on Tuesday accepted that Russia's Sputnik V vaccine against coronavirus has got the emergency use authorisation, making it the third vaccine apart from Covishield and Covaxin to be used in India.